The Biomechanical Foundation of Vascular Development

Blood vessels are not passive conduits. They are living structures that sense, respond to, and remodel under the constant influence of mechanical forces generated by cardiac output and peripheral resistance. The endothelium and surrounding vascular smooth muscle cells experience two primary mechanical stimuli: shear stress from blood flow and circumferential stretch from pressure. While shear stress acts predominantly on endothelial cells at the luminal surface, mechanical stretching — also referred to as cyclic strain or wall distension — affects the entire vessel wall. This stretching is not merely a passive consequence of hemodynamics; it is an active instructional signal that drives the maturation of vascular tissues from embryonic development through postnatal growth and into adult homeostasis.

During development, the nascent vascular plexus forms through vasculogenesis and angiogenesis, but these primitive vessels lack the structural integrity, contractile tone, and barrier function of mature blood vessels. Maturation transforms these fragile tubes into robust, functionally specialized conduits. Mechanical stretching is a central orchestrator of this transformation. Research has shown that vessels exposed to physiological levels of cyclic strain exhibit increased wall thickness, enhanced extracellular matrix (ECM) organization, and improved mechanical compliance compared to vessels cultured under static conditions. The magnitude, frequency, duration, and waveform of the stretch all contribute to distinct cellular and tissue-level outcomes. For instance, physiological circumferential stretch (typically 5–15% strain at 1 Hz in humans) promotes a quiescent, contractile phenotype in smooth muscle cells, whereas pathological overstretch (exceeding 20% strain) can trigger inflammatory and proliferative responses that resemble vascular disease.

Hemodynamic Forces Shaping the Vasculature

The cardiovascular system operates under tightly regulated pressure and flow regimes. Arteries, in particular, are subjected to pulsatile pressure that produces cyclic distension. The wall tension generated by this pressure is described by the Law of Laplace, where wall stress is proportional to vessel radius and transmural pressure. During development, increasing blood pressure and flow rates impose progressively greater mechanical loads on growing vessels. This mechanical loading is not uniform; it varies by anatomical location, vessel caliber, and physiological state. The result is a regionally specific pattern of vascular maturation that matches mechanical demand. For example, large elastic arteries like the aorta develop prominent elastic lamellae to absorb and store energy during systole, while smaller muscular arteries develop thicker smooth muscle layers to regulate diameter and resistance. These adaptations are driven, in large part, by the specific mechanical stretching patterns each vessel experiences.

Experimental studies using animal models and in vitro systems have demonstrated that removing or altering mechanical stretch during development leads to impaired vascular maturation. Vessels cultured under static conditions (no stretch) fail to develop adequate wall thickness, show disorganized ECM, and exhibit poor contractile responses. When cyclic stretch is applied at physiological levels, these deficits are rescued, and the vessels acquire mature characteristics including aligned smooth muscle layers, organized collagen and elastin fibers, and functional endothelial barriers. The mechanical environment is therefore not a passive backdrop but an active determinant of vascular tissue quality.

Circumferential Stretch and Wall Tension

Circumferential stretch is the dominant mechanical signal in the vessel wall. As the heart ejects blood into the aorta, the pressure wave propagates down the arterial tree, causing each segment to distend. This distension is sensed by vascular cells through multiple mechanisms. The magnitude of stretch is determined by the pulse pressure and the mechanical properties of the vessel wall itself. Stiffer vessels experience less distension for a given pressure change, while more compliant vessels stretch more. During development and maturation, the vessel wall undergoes significant remodeling that alters its mechanical properties, creating a dynamic feedback loop between stretch and structure.

Importantly, cells within the vessel wall do not experience stretch uniformly. Endothelial cells, located at the luminal surface, are exposed to both shear stress and circumferential stretch, while smooth muscle cells in the medial layer are primarily subjected to circumferential and axial stretch. The extracellular matrix transmits these forces between cells and across layers. Collagen fibers provide tensile strength and limit excessive distension, while elastin fibers allow reversible deformation. During maturation, the synthesis and organization of these ECM components are tightly regulated by mechanical signals. Cyclic stretch upregulates the expression of collagen types I and III, elastin, fibronectin, and proteoglycans in vascular smooth muscle cells, and promotes the cross-linking and alignment of these molecules into a mature, load-bearing matrix. Without mechanical stretch, ECM production is reduced, and the matrix that is produced is poorly organized, leading to mechanically weak vessels that are prone to failure.

Cellular Responses to Mechanical Stretching

The effects of mechanical stretching on vascular tissue maturation are ultimately mediated by the cellular components of the vessel wall. Each cell type responds to stretch in a distinct but coordinated manner, leading to the integrated tissue-level changes that characterize maturation. Understanding these cellular responses is essential for both basic vascular biology and for engineering functional vascular replacements.

Endothelial Cell Alignment and Function

Endothelial cells line the luminal surface of all blood vessels and form the critical barrier between blood and tissue. They are exquisitely sensitive to mechanical forces, particularly shear stress, but also respond to cyclic stretch. When endothelial cells are subjected to uniaxial cyclic stretch, they align their long axes perpendicular to the direction of stretch. This alignment is a protective adaptation that reduces mechanical strain on individual cells and maintains barrier integrity. Aligned endothelial monolayers exhibit reduced permeability, improved junctional protein organization, and enhanced resistance to flow-induced damage. During vascular maturation, the acquisition of a well-aligned, confluent endothelial monolayer is a hallmark of functional vessels.

Beyond alignment, stretch influences endothelial cell proliferation, migration, and gene expression. Physiological levels of cyclic stretch maintain endothelial quiescence and promote the expression of anti-thrombotic and anti-inflammatory factors such as nitric oxide (NO) and prostacyclin. Endothelial NO synthase (eNOS) activity is upregulated by stretch through mechanosensitive pathways, leading to NO production that relaxes underlying smooth muscle and regulates vascular tone. This paracrine signaling between endothelial cells and smooth muscle cells is essential for mature vessel function, including flow-mediated dilation. In contrast, pathological stretch patterns — such as those seen in hypertension — can disrupt endothelial function, promoting inflammation, leukocyte adhesion, and permeability. The mechanical environment therefore directly shapes endothelial maturation and the long-term health of the vessel.

Smooth Muscle Cell Differentiation and Phenotype

Vascular smooth muscle cells (VSMCs) are the primary contractile and synthetic cells of the vessel wall. Unlike many cell types, VSMCs exhibit remarkable phenotypic plasticity, ranging from a quiescent, contractile phenotype to a proliferative, synthetic phenotype. The contractile phenotype is characteristic of mature, healthy blood vessels and is defined by the expression of contractile proteins such as α-smooth muscle actin (α-SMA), smooth muscle myosin heavy chain (SM-MHC), calponin, and SM22α. These cells generate active tension and regulate vessel diameter. The synthetic phenotype, in contrast, is associated with proliferation, migration, and ECM production, and is more common in developing vessels, injured vessels, and atherosclerotic lesions.

Mechanical stretching is a powerful regulator of VSMC phenotype. Physiological cyclic stretch promotes the contractile phenotype by upregulating contractile protein expression and reducing proliferation. This occurs through the activation of specific signaling pathways including RhoA/ROCK, which stabilizes actin filaments and promotes actomyosin contractility, and through the transcription factor myocardin, a master regulator of smooth muscle differentiation. VSMCs cultured under cyclic stretch show increased expression of α-SMA and SM-MHC, organized into aligned actin bundles, and exhibit enhanced contractile responses to vasoactive agents such as angiotensin II and phenylephrine. The stretch frequency and amplitude are critical: low-frequency stretching (0.1 Hz) does not promote differentiation, while physiological frequencies (1 Hz) are effective. Additionally, the duration of stimulation matters — prolonged exposure (days to weeks) is required for full phenotypic maturation.

Static culture conditions, or application of non-physiological stretch patterns (e.g., static stretch without cyclic component), fail to induce the contractile phenotype and instead promote a synthetic, immature state. This has direct implications for tissue engineering: vascular grafts cultured under static conditions typically contain synthetic, non-contractile VSMCs that produce a disorganized ECM and lack mechanical integrity. In contrast, grafts subjected to dynamic mechanical conditioning develop contractile VSMCs and robust mechanical properties that approach those of native arteries.

Extracellular Matrix Remodeling

The ECM is the structural scaffold of the vessel wall, providing mechanical support and transmitting forces between cells. It is composed primarily of collagen, elastin, proteoglycans, and glycoproteins. During vascular maturation, the ECM undergoes substantial remodeling: collagen content increases, fiber diameter grows, cross-linking matures, and elastin forms organized lamellar structures. These changes confer the vessel with the mechanical properties necessary for lifelong function — high tensile strength for burst resistance, elastic recoil for energy storage, and viscoelastic damping for pulse wave attenuation.

Mechanical stretching directly regulates ECM synthesis and organization. VSMCs and fibroblasts in the vessel wall respond to stretch by upregulating the expression of collagens (especially type I and type III), elastin, fibronectin, and lysyl oxidase (LOX), the enzyme responsible for collagen and elastin cross-linking. Stretch also promotes the spatial organization of ECM fibers. For example, collagen fibrils align circumferentially in response to cyclic stretch, enhancing the vessel's ability to resist circumferential stress. This alignment is mediated by cell-based traction forces that orient newly synthesized ECM along the direction of principal strain. In the absence of mechanical stretch, ECM deposition is reduced, fibers are disorganized, and cross-linking is insufficient, resulting in mechanically weak tissue that cannot withstand physiological pressures.

The mechanical properties of the ECM, in turn, influence how cells perceive stretch. Stiffer matrices amplify cellular strain for a given applied deformation, while compliant matrices reduce it. This creates a mechano-regulatory loop: cells produce and remodel ECM in response to stretch, and the resulting ECM stiffness modulates further cellular responses. During maturation, this loop culminates in a stable, tissue-specific mechanical state that is matched to the hemodynamic environment. The importance of this process is underscored by the fact that defects in ECM remodeling — such as those caused by mutations in elastin or collagen genes — lead to severe vascular pathologies, including aortic aneurysms, dissections, and arterial stenoses. Understanding how mechanical stretch orchestrates ECM maturation is therefore relevant not only for tissue engineering but also for understanding developmental defects and disease.

Molecular Mechanisms of Mechanotransduction

The conversion of mechanical stretch into biochemical signals — mechanotransduction — involves a coordinated network of sensors, transducers, effectors, and feedback loops. These molecular mechanisms enable cells to detect forces, amplify signals, and execute appropriate transcriptional and post-translational responses. A detailed understanding of these pathways is critical for designing rational interventions to enhance vascular maturation in tissue engineering and to treat vascular diseases.

Integrin-Mediated Signaling

Integrins are transmembrane receptors that link the ECM to the cytoskeleton. They are the primary mechanosensors in vascular cells. When the ECM is stretched, integrins undergo conformational changes that increase their affinity for ECM ligands (such as fibronectin, collagen, and laminin) and promote clustering at focal adhesions. Clustered integrins recruit adaptor proteins including talin, vinculin, paxillin, and focal adhesion kinase (FAK). These proteins form a signaling platform that connects the ECM to the actin cytoskeleton and activates downstream cascades. FAK autophosphorylation at Tyr397 creates a binding site for Src family kinases, leading to activation of the Ras-ERK/MAPK pathway, which promotes cell survival, proliferation, and ECM production. FAK also activates the Rho family GTPases RhoA, Rac1, and Cdc42, which regulate actin dynamics, cell shape, and contractility.

The integrin-cytoskeleton linkage is not static; it undergoes dynamic strengthening in response to force — a process known as "catch-bond" behavior. Increased force strengthens the integrin-ligand bond, allowing prolonged signaling. This enables cells to sense the magnitude and duration of stretch and to adjust their responses accordingly. For example, sustained stretch leads to sustained FAK activation and downstream signaling, promoting long-term changes in gene expression that underpin maturation. In VSMCs, integrin-mediated mechanotransduction is essential for stretch-induced differentiation. Blocking integrin β1 or inhibiting FAK activity prevents stretch-induced upregulation of contractile proteins, indicating that this pathway is necessary for the maturation response.

Stretch-Activated Ion Channels

Stretch-activated ion channels (SACs) are membrane proteins that open in response to mechanical deformation of the lipid bilayer or cytoskeletal connections. In vascular cells, SACs conduct cations including Na+, K+, and Ca2+. The resulting influx of Ca2+ is especially important, as it triggers a wide range of downstream effects. In endothelial cells, SAC-mediated Ca2+ entry activates eNOS and promotes NO production. In VSMCs, Ca2+ entry through SACs can activate calmodulin, myosin light chain kinase, and contraction, as well as Ca2+-dependent transcription factors.

Several SACs have been identified in vascular cells, including members of the transient receptor potential (TRP) family, such as TRPC6, TRPV4, and TRPM7. TRPC6 is expressed in VSMCs and is activated by membrane stretch and diacylglycerol. It is required for stretch-induced depolarization and contraction. TRPV4 is more abundant in endothelial cells and is involved in shear stress and stretch responses. These channels are not redundant; they provide distinct contributions to mechanotransduction based on their specific biophysical properties, expression patterns, and coupling to downstream effectors. Pharmacological blockade of SACs or genetic deletion of specific TRP channels impairs vascular responses to stretch, including vasoconstriction and gene expression changes, highlighting their central role in mechanotransduction.

Intracellular Kinase Cascades: MAPK and PI3K/Akt

Mechanical stretch activates multiple intracellular kinase cascades that converge on transcription factors and epigenetic regulators to alter gene expression. The mitogen-activated protein kinase (MAPK) pathway is a major mediator. Stretch activates ERK1/2, JNK, and p38 MAPK through upstream activators including integrin-FAK signaling, growth factor receptors, and GPCRs. ERK1/2 is particularly associated with proliferation and ECM production, while p38 is linked to inflammation and apoptosis. The balance between these pathways determines the cellular outcome. In VSMCs, stretch at physiological levels preferentially activates ERK1/2 in a sustained manner that promotes contractile differentiation, while pathological overstretch can shift the balance toward JNK and p38, inducing inflammatory and synthetic programs.

The PI3K/Akt pathway is another key mediator. Stretch activates PI3K through integrins and receptor tyrosine kinases, leading to Akt phosphorylation. Akt promotes cell survival, growth, and metabolism, and also regulates the expression of contractile proteins in VSMCs through the transcription factor FoxO. Akt-mediated phosphorylation of FoxO proteins retains them in the cytoplasm, preventing their pro-apoptotic and pro-synthetic transcriptional programs. In this way, Akt signaling supports the mature contractile phenotype. The interplay between MAPK and PI3K/Akt pathways — including cross-talk and feedback — creates a complex signaling network that integrates mechanical information with growth factor and metabolic cues.

Downstream of these kinases, transcription factors including SRF, myocardin, MRTF-A/B, AP-1, and NF-κB regulate the expression of maturation-associated genes. The SRF-myocardin complex is a master regulator of VSMC contractile differentiation. Stretch triggers the nuclear translocation of MRTF-A/B, which co-activates SRF to drive expression of contractile protein genes. This process depends on actin dynamics — G-actin binds and sequesters MRTF-A/B, while F-actin (promoted by RhoA signaling) releases them to enter the nucleus. Stretch-induced actin polymerization is therefore a direct mechanical input that controls gene expression. This elegant mechanism confines the contractile phenotype to cells experiencing appropriate mechanical loading, ensuring that maturation is spatially and temporally coordinated with hemodynamic demands.

Mechanical Stretching in Vascular Maturation and Disease

The principles of mechanical stretch-mediated maturation operate throughout life, but their importance is especially evident during development and in disease states where mechanical homeostasis is disrupted. Studying these contexts provides insight into the fundamental relationship between mechanics and vascular biology.

Developmental Maturation

In the embryo, the vascular system forms before a functional heart begins to beat. The first vessels are simple endothelial tubes with little structural organization. As the heart starts to contract and blood flows, these nascent vessels are exposed to increasing mechanical loads. This mechanical input is essential for maturation. In animal models where cardiac function is reduced (e.g., by genetic manipulation or pharmacological inhibition), vessels fail to mature — they remain thin-walled, poorly organized, and prone to rupture. The mechanical forces generated by the developing heart are therefore not incidental; they are necessary instructional signals that drive vessel wall assembly.

The process is self-reinforcing. Maturation increases vessel wall strength and compliance, which alters the mechanical environment and feeds back to further maturation. This positive feedback loop ensures that vessels develop in lockstep with increasing hemodynamic demands. For example, as blood pressure rises during fetal development, the vessel wall thickens and stiffens, maintaining appropriate wall stress. When this feedback loop is broken — as in conditions of chronically low pressure, such as those caused by congenital heart defects — vessels remain immature and are vulnerable to failure after birth. Understanding the mechanical requirements for developmental maturation has direct relevance for pediatric cardiology and for designing interventions to support vascular growth in conditions like hypoplastic left heart syndrome.

Pathological Remodeling in Hypertension and Atherosclerosis

In the adult, the mechanical environment is normally stable, but diseases such as hypertension perturb it. Elevated blood pressure increases circumferential wall stress and stretch. Vessels initially respond by thickening the wall to normalize stress — a process called outward hypertrophic remodeling. This is, in many ways, an adaptive maturation-like response: VSMCs undergo hypertrophy, ECM is deposited, and wall stiffness increases. However, if hypertension persists, the remodeling becomes maladaptive. The thickening is accompanied by fibrosis, inflammation, and reduced distensibility, leading to stiff, dysfunctional vessels that contribute to end-organ damage.

Atherosclerosis also involves mechanical factors, though the relationship is more complex. The disease preferentially affects regions of disturbed flow and altered stretch — for example, near bifurcations and curvatures where the mechanical environment is non-uniform. In these regions, endothelial cells do not align properly, and VSMCs adopt a synthetic, pro-inflammatory phenotype that promotes plaque formation. The mechanical features of the plaque itself — such as fibrous cap thickness and lipid core size — determine its stability and risk of rupture. These mechanical properties are shaped by the mechanical forces acting on the vessel wall. Understanding how mechanical stretching influences plaque composition and stability could lead to new strategies for preventing heart attacks and strokes.

Engineering Vascular Tissues with Mechanical Stimulation

The recognition that mechanical stretching drives vascular maturation has been transformative for tissue engineering. The goal of producing functional vascular grafts for surgical replacement — whether as coronary artery bypass grafts, peripheral vascular grafts, or arteriovenous shunts for dialysis — requires achieving tissue maturity that emulates native vessels. Mechanical conditioning in bioreactors has emerged as the most effective strategy to achieve this. The approach involves seeding vascular cells onto scaffold materials and subjecting them to controlled cyclic stretch in a bioreactor environment, often combined with luminal flow to provide shear stress.

Bioreactor Design and Mechanical Conditioning

Bioreactors for vascular tissue engineering must deliver precise, reproducible mechanical stimulation while maintaining sterile conditions and supporting cell viability. The simplest designs apply uniaxial cyclic stretch to tubular constructs through a pressurized culture medium. More advanced systems incorporate pulsatile flow, allowing simultaneous application of circumferential stretch (from intraluminal pressure) and shear stress (from flow). These bioreactors can be programmed to deliver specific pressure waveforms, frequencies, and amplitudes that mimic physiological conditions — for example, 120/80 mmHg at 1 Hz for arterial grafts. The duration of conditioning varies, with typical protocols ranging from 1 to 8 weeks. Longer durations generally produce more mature tissues, but practical considerations limit the culture period.

The choice of scaffold material is critical. Natural materials like decellularized vascular matrices, collagen gels, and fibrin gels provide a native-like environment but may have limited mechanical strength. Synthetic polymers such as polycaprolactone (PCL), poly(glycolic acid) (PGA), and poly(lactic-co-glycolic acid) (PLGA) offer high initial strength and controlled degradation but require surface modification to promote cell adhesion. Hybrid scaffolds that combine synthetic and natural components are an active area of research. Regardless of the material, the scaffold must be able to transmit mechanical forces to the seeded cells without breaking or deforming irreversibly. This imposes constraints on scaffold porosity, fiber alignment, and mechanical properties.

Optimizing Stretch Protocols for Tissue-Engineered Grafts

Not all stretch protocols are equally effective. The optimal protocol depends on the cell type, scaffold material, and desired tissue properties. Current research is systematically investigating the effects of stretch magnitude, frequency, duration, and waveform. For VSMC maturation, physiological stretch (5–15% cyclic strain at 1 Hz) promotes contractile differentiation and ECM organization. Lower magnitudes or static stretch are insufficient; higher magnitudes or non-physiological frequencies can be detrimental, causing cell damage or dedifferentiation. The duration of exposure matters as well — several weeks of daily cyclic stretch are needed to achieve stable mature phenotypes. Intermittent stretch (e.g., 1 hour on, 1 hour off) may be as effective as continuous stretch in some systems, potentially reducing bioreactor wear and energy consumption.

One critical variable is the time of initiation of mechanical stimulation. If stretch is applied immediately after cell seeding, it can disrupt cell attachment and lead to poor outcomes. A period of static culture (typically 1–7 days) allows cells to attach, spread, and begin producing ECM before mechanical loading begins. This "maturation phase" followed by a "conditioning phase" mirrors the natural developmental sequence where early tissue assembly occurs under relatively static conditions and later maturation is driven by increasing mechanical loads. Evidence from multiple groups indicates that this sequential approach yields superior tissue properties compared to constant loading or no loading. The final step is a "testing phase" where the graft is subjected to supraphysiological pressures to assess burst strength and suture retention — key benchmarks for clinical translation.

Challenges and Opportunities in Preclinical Models

Despite impressive progress, challenges remain. The tissue-engineered grafts produced to date often fall short of native vessel mechanical properties, particularly in terms of compliance and elastic recoil. Many grafts are stiffer than native arteries, which can lead to compliance mismatch with the host vessel and graft failure. The lack of organized elastin in engineered tissues is a major limitation because elastin is critical for elastic recoil and long-term durability. Additionally, the long culture times (4–8 weeks) required for maturation are impractical for clinical use, where grafts must be available on demand.

Efforts to address these challenges include developing faster maturation protocols using higher-frequency or variable-amplitude stretch, incorporating growth factors and other biochemical cues to synergize with mechanical stimulation, and using advanced biomaterials that mimic the mechanical properties of native tissues. Co-culture systems that include endothelial cells, VSMCs, and fibroblasts more accurately recapitulate the cellular diversity of the vessel wall and have shown promise for producing more mature tissues. In vivo studies in animal models — including rats, rabbits, pigs, and non-human primates — have demonstrated that mechanically conditioned grafts can maintain patency, resist thrombosis, and undergo host remodeling. The next frontier is to demonstrate long-term function and safety in human clinical trials.

Future Directions and Clinical Translation

The field of mechanically stimulated vascular tissue maturation is advancing rapidly. As researchers deepen their understanding of the molecular mechanisms and refine engineering approaches, several promising directions are emerging that could transform the treatment of vascular disease.

Personalized Mechanical Stimulation

Each patient has unique hemodynamics, vascular anatomy, and disease states. It is increasingly feasible to tailor mechanical stimulation protocols to individual patients. Using patient-specific imaging data (e.g., CT angiography, 4D flow MRI) and computational fluid dynamics, it is possible to compute the mechanical forces that a graft will experience once implanted. This information can be used to program a bioreactor to apply personalized stretch profiles that match the patient's own physiology. Such personalized conditioning could improve graft integration and long-term performance. Early proof-of-concept studies have shown that grafts conditioned with patient-specific hemodynamic loads produce tissue properties that are better matched to the host than grafts conditioned with generic protocols. This represents a significant step toward precision tissue engineering.

Integrating Mechanical and Biochemical Cues

Mechanical stimulation does not act in isolation. In the body, growth factors, hormones, and metabolic signals cooperate with mechanical forces to regulate vascular development and homeostasis. Researchers are now exploring how to combine mechanical stretch with biochemical factors to accelerate and enhance maturation. For example, adding transforming growth factor β (TGF-β) or platelet-derived growth factor (PDGF) in concert with cyclic stretch can amplify ECM production and VSMC differentiation beyond what either stimulus alone achieves. Similarly, small molecule agonists of mechanosensitive pathways, such as activators of RhoA or TRP channels, could be used to lower the threshold for stretch responses and reduce the required mechanical loading duration.

The challenge is identifying optimal combinations and timing. Too much of a growth factor can drive pathological responses (e.g., fibrosis or hyperplasia), while too little may be ineffective. The interplay between mechanical and biochemical signals is non-linear, and the system must be characterized carefully to avoid unexpected outcomes. High-throughput screening approaches and computational models of mechanochemical signaling are being developed to predict optimal protocols. These tools could eventually enable the rational design of conditioning regimens tailored to specific cell sources and clinical applications.

Extending to Other Vascular Beds and Species

While much of the research has focused on arterial grafts, mechanical stimulation is relevant to other vascular contexts. Venous grafts, which are commonly used in coronary artery bypass but suffer from poor long-term patency due to neointimal hyperplasia, may benefit from mechanical conditioning to promote venous-specific maturation and reduce disease. Lymphatic vessels, which also experience mechanical forces from interstitial fluid pressure and lymphatic pumping, are emerging as another target for tissue engineering. Even microvascular networks, such as those needed for vascularized tissues and organoids, could be conditioned mechanically through the application of cyclic stretch to the supporting matrix. Extending these principles across different vascular beds and species will broaden the impact of the technology.

The question of species-specific differences is particularly important for preclinical testing. Porcine and ovine models are commonly used because their cardiovascular physiology and size are similar to humans, but there are important differences in vessel wall structure, cellular responses, and mechanical properties. Recognizing these differences and accounting for them in study design is essential for successful translation. Human cells and tissues remain the gold standard for in vitro maturation studies, and the development of human induced pluripotent stem cell (iPSC)-derived vascular cells offers the potential for autologous tissue-engineered grafts that are patient-specific and immunologically compatible. Combining iPSC technology with personalized mechanical conditioning could ultimately enable the routine production of patient-ready vascular grafts.

Conclusion

Mechanical stretching is not a secondary influence in vascular tissue maturation — it is a primary driver. From the earliest stages of embryonic development to the maintenance of adult vessel homeostasis, the physical forces of blood pressure and flow shape the structure, composition, and function of blood vessels. The cellular and molecular mechanisms that transduce these forces into biological responses are increasingly well understood, and this knowledge is being translated into effective strategies for engineering vascular tissues. Bioreactor-based mechanical conditioning produces grafts with mature mechanical properties, organized ECM, and contractile smooth muscle cells — features that are essential for clinical success. As the field moves forward, personalized stimulation protocols, integrated mechanochemical strategies, and expanded applications to diverse vascular beds promise to make tissue-engineered blood vessels a routine clinical reality. The vessel wall is a mechanoresponsive organ, and by harnessing mechanical forces, we can build better vessels.

For those seeking deeper technical details, the foundational mechanobiology is reviewed in Humphrey et al. (Annual Review of Biomedical Engineering), while tissue engineering applications are covered extensively in Li et al. (Biomaterials). The role of mechanotransduction pathways in vascular development is summarized in Korn et al. (Current Biology). For a clinical perspective on mechanical forces and vascular disease, Humphrey (Nature Reviews Cardiology) provides an authoritative overview.